...
vrdn-img

Viridian Therapeutics Inc, Common Stock

VRDN

NAQ

$19.38

-$1.44

(-6.92%)

1D
Industry: Biotechnology Sector: Health Care

Analyst Forecast

Price Chart

Key Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$1.71B
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
1.82M
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
1.11
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$11.4 L
$27.2 H
$19.38

About Viridian Therapeutics Inc, Common Stock

Viridian Therapeutics, Inc., a biotechnology company, discover and develops treatments for serious and rare diseases. The company's product pipeline includes VRDN-001, a monoclonal antibody targeting insulin-like growth factor-1 receptor that is in Phase 3 clinical trial for the treatment of thyroid eye disease (TED); and VRDN-003, a next generation IGF-1R humanized monoclonal antibodies targeting IGF-1R and incorporating half-life extension technology for the treatment of TED. It also provides VRDN-006 a preclinical program for autoimmune disease. In addition, the company offers VRDN-006 and VRDN-008 a preclinical program for autoimmune disease. The company was formerly known as Miragen Therapeutics, Inc. and changed its name to Viridian Therapeutics, Inc. in January 2021.Viridian Therapeutics, Inc. was founded in 2010 and is headquartered in Waltham, Massachusetts. more

Industry: BiotechnologySector: Health Care

Returns

Time FrameVRDNSectorS&P500
1-Week Return-0.24%-2.06%-0.55%
1-Month Return-6.93%-1.92%2.72%
3-Month Return-10.11%-10.4%7.66%
6-Month Return55.42%-4.6%10.15%
1-Year Return-10.07%4.06%27.53%
3-Year Return-4.87%1.94%32.31%
5-Year Return158.61%36.48%89.2%
10-Year Return-96.63%97.46%194.59%

Financials

Dec '19Dec '20Dec '21Dec '22Dec '235YR TREND
Total Revenue4.46M1.05M2.96M1.77M314.00K[{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":23.54,"profit":true},{"date":"2021-12-31","value":66.42,"profit":true},{"date":"2022-12-31","value":39.72,"profit":true},{"date":"2023-12-31","value":7.04,"profit":true}]
Cost of Revenue32.79M28.30M620.00K755.00K1.32M[{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":86.31,"profit":true},{"date":"2021-12-31","value":1.89,"profit":true},{"date":"2022-12-31","value":2.3,"profit":true},{"date":"2023-12-31","value":4.03,"profit":true}]
Gross Profit(28.33M)(27.25M)2.34M1.02M(1.01M)[{"date":"2019-12-31","value":-1209.26,"profit":false},{"date":"2020-12-31","value":-1163.21,"profit":false},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":43.41,"profit":true},{"date":"2023-12-31","value":-43.02,"profit":false}]
Gross Margin(635.13%)(2595.62%)79.08%57.39%(321.02%)[{"date":"2019-12-31","value":-803.19,"profit":false},{"date":"2020-12-31","value":-3282.47,"profit":false},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":72.58,"profit":true},{"date":"2023-12-31","value":-405.97,"profit":false}]
Operating Expenses46.44M41.57M82.69M136.08M254.76M[{"date":"2019-12-31","value":18.23,"profit":true},{"date":"2020-12-31","value":16.32,"profit":true},{"date":"2021-12-31","value":32.46,"profit":true},{"date":"2022-12-31","value":53.41,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Operating Income(41.98M)(110.38M)(79.73M)(134.30M)(254.45M)[{"date":"2019-12-31","value":-4197900000,"profit":false},{"date":"2020-12-31","value":-11038000000,"profit":false},{"date":"2021-12-31","value":-7972800000,"profit":false},{"date":"2022-12-31","value":-13430400000,"profit":false},{"date":"2023-12-31","value":-25445000000,"profit":false}]
Total Non-Operating Income/Expense212.00K(670.00K)630.00K8.86M32.09M[{"date":"2019-12-31","value":0.66,"profit":true},{"date":"2020-12-31","value":-2.09,"profit":false},{"date":"2021-12-31","value":1.96,"profit":true},{"date":"2022-12-31","value":27.61,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Pre-Tax Income(41.87M)(110.72M)(79.41M)(129.87M)(237.73M)[{"date":"2019-12-31","value":-4187300000,"profit":false},{"date":"2020-12-31","value":-11071500000,"profit":false},{"date":"2021-12-31","value":-7941300000,"profit":false},{"date":"2022-12-31","value":-12987400000,"profit":false},{"date":"2023-12-31","value":-23773400000,"profit":false}]
Income Taxes547.00K269.00K3.00K(4.43M)18.56M[{"date":"2019-12-31","value":2.95,"profit":true},{"date":"2020-12-31","value":1.45,"profit":true},{"date":"2021-12-31","value":0.02,"profit":true},{"date":"2022-12-31","value":-23.86,"profit":false},{"date":"2023-12-31","value":100,"profit":true}]
Income After Taxes(42.42M)(110.98M)(79.42M)(125.44M)(256.30M)[{"date":"2019-12-31","value":-4242000000,"profit":false},{"date":"2020-12-31","value":-11098400000,"profit":false},{"date":"2021-12-31","value":-7941600000,"profit":false},{"date":"2022-12-31","value":-12544400000,"profit":false},{"date":"2023-12-31","value":-25629700000,"profit":false}]
Income From Continuous Operations(41.87M)(110.72M)(79.56M)(130.11M)(216.66M)[{"date":"2019-12-31","value":-4187300000,"profit":false},{"date":"2020-12-31","value":-11071500000,"profit":false},{"date":"2021-12-31","value":-7956200000,"profit":false},{"date":"2022-12-31","value":-13010700000,"profit":false},{"date":"2023-12-31","value":-21665900000,"profit":false}]
Income From Discontinued Operations-----[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Net Income(42.42M)(110.98M)(79.42M)(125.44M)(237.73M)[{"date":"2019-12-31","value":-4242000000,"profit":false},{"date":"2020-12-31","value":-11098400000,"profit":false},{"date":"2021-12-31","value":-7941600000,"profit":false},{"date":"2022-12-31","value":-12544400000,"profit":false},{"date":"2023-12-31","value":-23773400000,"profit":false}]
EPS (Diluted)(20.10)(11.31)(7.69)(4.03)(5.32)[{"date":"2019-12-31","value":-2010,"profit":false},{"date":"2020-12-31","value":-1131,"profit":false},{"date":"2021-12-31","value":-769,"profit":false},{"date":"2022-12-31","value":-403,"profit":false},{"date":"2023-12-31","value":-532,"profit":false}]

Ratios

Liquidity

These ratios help you determine the liquidity of the company. Higher is better.

VRDN
Cash Ratio 18.21
Current Ratio 18.55

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

VRDN
ROA (LTM) -32.15%
ROE (LTM) -51.88%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

VRDN
Debt Ratio Lower is generally better. Negative is bad. 0.08
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.92

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

VRDN
Trailing PE NM
Forward PE NM
P/S (TTM) 5649.81
P/B 3.29
Price/FCF NM
EV/R 3850.99
EV/Ebitda NM

FAQs

What is Viridian Therapeutics Inc share price today?

Viridian Therapeutics Inc (VRDN) share price today is $19.38

Can Indians buy Viridian Therapeutics Inc shares?

Yes, Indians can buy shares of Viridian Therapeutics Inc (VRDN) on Vested. To buy Viridian Therapeutics Inc from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in VRDN stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Viridian Therapeutics Inc be purchased?

Yes, you can purchase fractional shares of Viridian Therapeutics Inc (VRDN) via the Vested app. You can start investing in Viridian Therapeutics Inc (VRDN) with a minimum investment of $1.

How to invest in Viridian Therapeutics Inc shares from India?

You can invest in shares of Viridian Therapeutics Inc (VRDN) via Vested in three simple steps:

  • Click on Sign Up or Invest in VRDN stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Viridian Therapeutics Inc shares
What is Viridian Therapeutics Inc 52-week high and low stock price?

The 52-week high price of Viridian Therapeutics Inc (VRDN) is $27.2. The 52-week low price of Viridian Therapeutics Inc (VRDN) is $11.4.

What is Viridian Therapeutics Inc price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Viridian Therapeutics Inc (VRDN) is

What is Viridian Therapeutics Inc price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Viridian Therapeutics Inc (VRDN) is 3.29

What is Viridian Therapeutics Inc dividend yield?

The dividend yield of Viridian Therapeutics Inc (VRDN) is 0.00%

What is the Market Cap of Viridian Therapeutics Inc?

The market capitalization of Viridian Therapeutics Inc (VRDN) is $1.71B

What is Viridian Therapeutics Inc’s stock symbol?

The stock symbol (or ticker) of Viridian Therapeutics Inc is VRDN

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top